Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia. (Q47590490)
Jump to navigation
Jump to search
scientific article published on 15 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia. |
scientific article published on 15 November 2017 |
Statements
1 reference
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia. (English)
1 reference
Fu Li
1 reference
May Kung Sutherland
1 reference
Changpu Yu
1 reference
Roland B Walter
1 reference
Lori Westendorf
1 reference
John Valliere-Douglass
1 reference
Lucy Pan
1 reference
Ashley Cronkite
1 reference
Django Sussman
1 reference
Kerry Klussman
1 reference
Michelle Ulrich
1 reference
Martha E Anderson
1 reference
Ivan J Stone
1 reference
Weiping Zeng
1 reference
Mechthild Jonas
1 reference
Timothy S Lewis
1 reference
Maitrayee Goswami
1 reference
Sa A Wang
1 reference
Peter D Senter
1 reference
Che-Leung Law
1 reference
Eric J Feldman
1 reference
Dennis R Benjamin
1 reference
15 November 2017
1 reference
Identifiers
1 reference
1 reference